Embolization of iliac metastasis during lenvatinib treatment in patient with advanced Hürthle cell thyroid carcinoma

Future Oncology
Rossella RodiaStefano Mariotti

Abstract

Lenvatinib is a tyrosine kinase inhibitor (TKI) with antiproliferative and antiangiogenic effects indicated for the treatment of progressive, locally advanced or metastatic progressive thyroid carcinoma, refractory to radioactive iodine therapy. Antiangiogenic therapies induce ischemic necrosis of tumor tissue, with increased risk of hemorrhagic complications. The management of hemorrhagic risk is based on precautionary measures and for any surgical procedure, it is advised to interrupt the treatment in order to avoid complications. 'Flare-up' of tumor activity may follow TKI interruption. However, it is not known if continuing TKIs during minimally invasive interventions is safe. We report here the first case in which an embolization of metastasis is performed without interrupting lenvatinib treatment. The procedure was successful and free of complications.

References

Mar 24, 1998·Annual Review of Medicine·B R Zetter
Jan 8, 2003·Seminars in Oncology·Judah Folkman
Oct 4, 2006·The Journal of Clinical Investigation·Michael R MancusoDonald M McDonald
May 25, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·J Ayllon, G Pignot
Mar 1, 2011·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·G PignotM Zerbib
Jun 15, 2012·Thrombosis Research·Francesca Elice, Francesco Rodeghiero
Nov 1, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Austin DuffyTim F Greten
Feb 12, 2015·The New England Journal of Medicine·Martin SchlumbergerSteven I Sherman
Jun 25, 2015·Cancer Treatment Reviews·Raquel M CarneiroFrancis J Giles
Feb 23, 2017·Archives of Endocrinology and Metabolism·Angelica SchmidtMartin J Schlumberger
Mar 9, 2017·Endocrine-related Cancer·Marcia S BroseIwao Sugitani
Mar 19, 2019·Endocrinology, Diabetes & Metabolism Case Reports·Taisuke UchidaMasamitsu Nakazato

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Robert H Caplan
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
J Ayllon, G Pignot
Annales d'endocrinologie
N BourcigauxB Charbonnel
© 2021 Meta ULC. All rights reserved